SCHEMBL2484931

SCHEMBL2484931

CCc1cc(O)c(C(C)(C)C)cc1Sc1cc(C(C)(C)C)c(O)cc1CC

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 7/20 0.61
ALDH1A1 P00352 5/20 0.61
SMN1; SMN2 Q16637 4/20 0.61
TP53 P04637 3/20 0.61
CYP3A4 P08684 3/20 0.61
HIF1A Q16665 3/20 0.61
TSHR P16473 2/20 0.61
MAPK1 P28482 2/20 0.61
TDP1 Q9NUW8 1/20 0.61
MAPT P10636 3/20 0.52
CYP1A2 P05177 2/20 0.52
KDM4E B2RXH2 1/20 0.52
ATP2A2 P16615 1/20 0.52
ATP2A3 Q93084 1/20 0.52
HSPA5 P11021 2/20 0.44
CYP2C9 P11712 3/20 0.44
CYP2C19 P33261 2/20 0.44
CYP2D6 P10635 2/20 0.44
LMNA P02545 3/20 0.40
HPGD P15428 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29517048 1.00 ALOX15 (0.61) ALOX15ALDH1A1SMN1; SMN2TP53CYP3A4
SCHEMBL2483068 0.87 ALOX15 (0.56) ALOX15ALDH1A1SMN1; SMN2TP53CYP3A4
SCHEMBL27559201 0.85 ALOX15 (0.58) ALOX15ALDH1A1SMN1; SMN2TP53CYP3A4
SCHEMBL2477818 0.84 ALOX15 (0.53) ALOX15ALDH1A1SMN1; SMN2TP53CYP3A4
SCHEMBL2484356 0.82 ALOX15 (0.54) ALOX15ALDH1A1SMN1; SMN2TP53CYP3A4
SCHEMBL31267398 0.82 ALOX15 (0.50) ALOX15ALDH1A1SMN1; SMN2TP53CYP3A4
SCHEMBL2788258 0.82 ALOX15 (0.58) ALOX15ALDH1A1SMN1; SMN2TP53CYP3A4
SCHEMBL29808669 0.82 ALOX15 (0.58) ALOX15ALDH1A1SMN1; SMN2TP53CYP3A4
SCHEMBL2485961 0.79 ALOX15 (0.70) ALOX15ALDH1A1SMN1; SMN2TP53CYP3A4
SCHEMBL8745976 0.79 ALOX15 (0.42) ALOX15ALDH1A1SMN1; SMN2TP53CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12531188-B2 Electrolytic capacitor PANASONIC INTELLECTUAL PROPERTY MANAGEMENT CO., LTD. (JP) 2026-01-20 US disclosed
US-12300445-B2 Electrolytic capacitor PANASONIC INTELLECTUAL PROPERTY MANAGEMENT CO., LTD. (JP) 2025-05-13 US disclosed
US-20230368982-A1 ELECTROLYTIC CAPACITOR PANASONIC INTELLECTUAL PROPERTY MANAGEMENT CO., LTD. (JP) 2023-11-16 US disclosed
US-20230260716-A1 ELECTROLYTIC CAPACITOR PANASONIC INTELLECTUAL PROPERTY MANAGEMENT CO., LTD. (JP) 2023-08-17 US disclosed
EP-1947725-B1 Polymer electrolyte composition and fuel cell SUMITOMO CHEMICAL CO (JP) 2011-10-19 EP disclosed
EP-1947725-A2 Polymer electrolyte composition and fuel cell Sumitomo Chemical Company, Limited (JP) 2008-07-23 EP disclosed
EP-1289041-B1 Polymer electrolyte composition and fuel cell SUMITOMO CHEMICAL CO (JP) 2008-03-12 EP disclosed
US-20070072979-A1 Dispersing agents in nanocomposites POLYMERS AUSTRALIA PTY, LIMITED (AU) 2007-03-29 US disclosed
US-20060257706-A1 POLYMER ELECTROLYTE COMPOSITION AND FUEL CELL HIDAKA YASUAKI 2006-11-16 US disclosed
US-20030113605-A1 Polymer electrolyte composition and fuel cell SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2003-06-19 US disclosed
EP-1289041-A2 Polymer electrolyte composition and fuel cell SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2003-03-05 EP disclosed
EP-0426024-B1 Process for incorporating organic fibrous fillers in elastomers DU PONT (US) 2000-04-12 EP disclosed
US-5989778-A INITIATOR, PHENOL-BASED ANTIOXIDANT, PHOTOCURING COMPONENTS: A BIFUNCTIONAL URETHANE ACRYLATE, AN EPOXY ACRYLATE HAVING BISPHENOL A SKELETON, AND AN N-VINYL LACTAM OF GIVEN FORMULA; PROTECTIVE COATINGS FOR DIGITAL VERSATILE DISKS (DVD) SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1999-11-23 US disclosed
US-5205972-A Coagulating the mixture of aqueous slurry and latex, feeding through flow restriction which applies back pressure to dehydrating E. I. DU PONT DE NEMOURS AND COMPANY (US) 1993-04-27 US disclosed
US-5169925-A Light stabilizers for polymers; photooxidation resistance; nondestructive; nondiffusing; heat resistance; molding materials HOECHST AKTIENGESELLSCHAFT (DE) 1992-12-08 US disclosed
EP-0270711-B1 IMPROVED METHOD FOR ROSIN ESTERIFICATION WESTVACO CORPORATION (US) 1992-04-22 EP disclosed
EP-0426024-A2 Process for incorporating organic fibrous fillers in elastomers E.I. DU PONT DE NEMOURS AND COMPANY (US) 1991-05-08 EP disclosed
US-4083626-A LIGHT DIFFUSION LAYER AND TRANSPARENT SUPPORT BONDED BY PHOTOCURABLE RESIN FUJI PHOTO FILM CO., LTD. (JA) 1978-04-11 US disclosed
US-4053208-A REAR PROJECTION SCREENS FUJI PHOTO FILM CO., LTD. (JA) 1977-10-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12531188-B2 Electrolytic capacitor ASIC1, SLC1A2, HCN2 ALOX15 4030/4885ALDH1A1 1325/4885SMN1; SMN2 2536/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.